Answers are grounded in this paper and cite their sources.
Main-group singlet biradicaloids have been thoroughly investigated in the past two decades, especially derivatives of cyclobutane-1,3-diyl. However, in each of the known examples, the radical centers are identical. Therefore, we sought to prepare a mixed dipnictadiazanediyls with P and As bearing the radical character. To achieve this goal, the unprecedented cyclodichloro arsaphosphadiazane [ClP(μ-NTer)2AsCl] had to be prepared first. Treatment of [ClP(μ-NTer)2AsCl] with a halide-abstracting agent led to the novel cyclic cation [P(μ-NTer)2AsCl](+), while reduction with magnesium afforded the first arsaphosphadiazanediyl [P(μ-NTer)2As].
No takes yet. Share an insight, caveat, or question.
Hinz et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: